AVITA Medical Inc. is a regenerative medicine company. It engages in developing and commercializing a technology platform which enables point-of-care autologous skin restoration for multiple unmet needs. AVITA Medical Inc., formerly known as AVITA Therapeutics Inc., is based in VALENCIA, Calif.
| Revenue (Most Recent Fiscal Year) | $64.25M |
| Net Income (Most Recent Fiscal Year) | $-61.85M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.83 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -68.87% |
| Net Margin (Trailing 12 Months) | -68.87% |
| Return on Equity (Trailing 12 Months) | -632.62% |
| Return on Assets (Trailing 12 Months) | -71.52% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.58 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.46 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 1.60 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.17 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.38 |
| Earnings per Share (Most Recent Fiscal Year) | $-2.39 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.97 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 26.62M |
| Free Float | 25.87M |
| Market Capitalization | $136.82M |
| Average Volume (Last 20 Days) | 1.31M |
| Beta (Past 60 Months) | 1.64 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.80% |
| Percentage Held By Institutions (Latest 13F Reports) | 27.66% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |